Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to $22.9 million.

  • Cresco Labs' Other Non-Current Assets rose 60251.53% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year increase of 60251.53%. This contributed to the annual value of $15.0 million for FY2024, which is 15066.89% up from last year.
  • As of Q3 2025, Cresco Labs' Other Non-Current Assets stood at $22.9 million, which was up 60251.53% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Cresco Labs' Other Non-Current Assets ranged from a high of $22.9 million in Q3 2025 and a low of -$5.4 million during Q3 2022
  • In the last 5 years, Cresco Labs' Other Non-Current Assets had a median value of $3.9 million in 2021 and averaged $4.6 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first plummeted by 102206.3% in 2021, then skyrocketed by 60251.53% in 2025.
  • Over the past 5 years, Cresco Labs' Other Non-Current Assets (Quarter) stood at $4.2 million in 2021, then skyrocketed by 124.18% to $9.4 million in 2022, then crashed by 36.64% to $6.0 million in 2023, then skyrocketed by 150.67% to $15.0 million in 2024, then soared by 52.78% to $22.9 million in 2025.
  • Its last three reported values are $22.9 million in Q3 2025, $3.2 million for Q2 2025, and $3.5 million during Q1 2025.